The impact of letrozole on oocyte quality in assisted reproductive technology (ART); a randomized double-blind clinical trial

References

• Huisman D, Raymakers X, Hoomans EH. Understanding the burden of ovarian stimulation: fertility expert and patient perceptions. Reprod BioMed Online. 2009;19(Suppl 2):5–10.
   PubMedGoogle Scholar
• Olivius C, Friden B, Borg G, et al. Why do couples discontinue in vitro fertilization treatment? A cohort study. Fertil Steril. 2004;81(2):258–261.
   PubMed Web of Science ®Google Scholar
• Crosignani PG. Good oocytes for successful IVF cycles. Middle East Fertil Soc J. 2014;19(3):153–155.
   Google Scholar
• Mikkelsen AL, Lindenberg S. Morphology of in-vitro matured oocytes: impact on fertility potential and embryo quality. Hum Reprod. 2001;16(8):1714–1718.
   PubMed Web of Science ®Google Scholar
• Macklon NS, Stouffer RL, Giudice LC, et al. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27(2):170–207.
   PubMed Web of Science ®Google Scholar
• Rubio C, Mercader A, Alamá P, et al. Prospective cohort study in high responder oocyte donors using two hormonal stimulation protocols: impact on embryo aneuploidy and development. Hum Reprod. 2010;25(9):2290–2297.
   PubMed Web of Science ®Google Scholar
• Baart EB, Martini E, Eijkemans MJ, et al. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod. 2007;22(4):980–988.
   PubMed Web of Science ®Google Scholar
• Venetis CA, Kolibianakis EM, Papanikolaou E, et al. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update. 2007;13(4):343–355.
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol. 2011;9:116.
   PubMed Web of Science ®Google Scholar
• Lebbe M, Woodruff TK. Involvement of androgens in ovarian health and disease. Mol Hum Reprod. 2013;19(12):828–837.
   PubMed Web of Science ®Google Scholar
• Vendola K, Zhou J, Wang J, et al. Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary. Hum Reprod. 1999;14(9):2328–2332.
   PubMed Web of Science ®Google Scholar
• Lee KH, Kim CH, Suk HJ, et al. The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization. Obstet Gynecol Sci. 2014;57(3):216–222.
   PubMedGoogle Scholar
• Winer EP, Hudis C, Burstein HJ, et al. American society of clinical oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol. 2002;20(15):3317–3327.
   PubMed Web of Science ®Google Scholar
• Yang A, Cui N, Sun Y-F, et al. Letrozole for female infertility. Front Endocrinol. 2021;12:676133.
   PubMed Web of Science ®Google Scholar
• Mitwally MFM, Casper RF. Aromatase inhibition a novel method of ovulation induction in women with polycystic ovary syndrome. Reprod Technol. 2000;10(5):244–247.
   Google Scholar
• Huang S, Wang R, Li R, et al. Ovarian stimulation in infertile women treated with the use of intrauterine insemination: a cohort study from China. Fertil Steril. 2018;109(5):872–878.
   PubMed Web of Science ®Google Scholar
• Teede HJ, Misso ML, Costello MF, International PCOS Network, et al. Recommendations from the international evidence‑based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–1618.
   PubMed Web of Science ®Google Scholar
• Liu W, Dong S, Li Y, et al. Randomised control trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate‑resistant polycystic ovary syndrome. Exp Ther Med. 2015;10(4):1297–1302.
   PubMed Web of Science ®Google Scholar
• Chen D, Shen X, Fu Y, et al. Pregnancy outcomes following letrozole use in frozen-thawed embryo transfer cycles: a systematic review and meta-analysis. Geburtshilfe Frauenheilkd. 2020;80(8):820–833.
   PubMedGoogle Scholar
• Tshzmachyan R, Hambartsoumian E. The role of letrozole (LE) in controlled ovarian stimulation (COS) in patients at high risk to develop ovarian hyper stimulation syndrome (OHSS). A prospective randomized controlled pilot study. J Gynecol Obstet Hum Reprod. 2020;49(2):101643.
   PubMed Web of Science ®Google Scholar
• Bercaire LMN, Donadio CM, Rocha NF, et al. The impact of letrozole administration on oocyte morphology in breast cancer patients undergoing fertility preservation. JBRA Assist Reprod. 2020;24(3):257–264.
   PubMed Web of Science ®Google Scholar
• Mai Q, Hu X, Yang G, et al. Effect of letrozole on moderate and severe early- onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial. Am J Obstet Gynecol. 2017;216(1):42 e1–10.
   PubMed Web of Science ®Google Scholar
• Haas J, Casper RF. In vitro fertilization treatments with the use of clomiphene citrate or letrozole. Fertil Steril. 2017;108(4):568–571.
   PubMed Web of Science ®Google Scholar
• Finn RS, Martin M, Rugo HS, et al. Palbociclib and letrozole in advanced breast cancer. N Engl J Med. 2016;375(20):1925–1936.
   PubMed Web of Science ®Google Scholar
• Pereira N, Hancock K, Cordeiro CN, et al. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes. Gynecol Endocrinol. 2016;32(10):823–826.
   PubMed Web of Science ®Google Scholar
• Ben-Haroush A, Werthermer A, Klochendler E, et al. Effect of letrozole added to gonadotropins in controlled ovarian stimulation protocols on the yield and maturity of retrieved oocytes. Gynecol Endocrinol. 2019;35(4):324–327.
   PubMed Web of Science ®Google Scholar
• Goldrat O, Steen GVD, Gonzalez-Merino E, et al. Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers. Reprod Biol Endocrinol. 2019;17(1):3.
   PubMedGoogle Scholar
• Humaidan P, Quartarolo JE, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril. 2010;94(2):389–400.
   PubMed Web of Science ®Google Scholar
• Sonigo C, Sermondade N, Calvo J, et al. Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients. Eur J Obstet Gynecol Reprod Biol X. 2019;4:100049.
   PubMedGoogle Scholar
• Lazer T, Dar S, Shlush E, et al. Comparison of IVF outcomes between minimal stimulation and high–dose stimulation for patients with poor ovarian reserve. Int J Reprod Med. 2014;2014:581451.
   PubMedGoogle Scholar
• Haas J, Bassil R, Gonen N, et al. The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins follicular fluid of patients co- treated during the stimulation cycle. Reprod Biol Endocrinol. 2018;16(1):54.
   PubMedGoogle Scholar
• Liang Y, Guo Q, Wu XH, et al. Does the additional use of clomiphene citrate or letrozole for in vitro fertilization deserve more attention. BMC Pregnancy Childbirth. 2021;21(1):275.
   PubMed Web of Science ®Google Scholar
• Moini A, Lavasani Z, Kashani L, et al. Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: a double-blind randomized clinical trial. Int J Reprod Biomed. 2019;17(9):653–660.
   PubMed Web of Science ®Google Scholar
• Shapira M, Orvieto R, Lebovitz O, et al. Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and Sub optimal responders? J Ovarian Res. 2020;13(1):66.
   PubMed Web of Science ®Google Scholar
• Yang X, Lin G, Lu G, et al. Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study. Reprod Biol Endocrinol. 2019;17(1):43.
   PubMedGoogle Scholar